Research and Development of the FDA ARGOS System Tender, USA - 118087300

Procurement Summary

Country : USA

Summary : Research and Development of the FDA ARGOS System

Deadline : 02 May 2025

Other Information

Notice Type : Tender

TOT Ref.No.: 118087300

Document Ref. No. : FDA-SSN-75F40125Q00090

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

This is not a solicitation announcement. This is a Sources Sought Notice (SSN) only. This SSN is issued solely for market research and planning purposes - it does not constitute a Request for Quotations (RFQ) or a promise to issue an RFQ in the future. Further, the SSN does not commit the Government to contract for any supply or service whatsoever. The FDA is not seeking proposals and will not accept any unsolicited proposals. Responders are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this SSN; all costs associated with responding to this SSN will be solely at the expense of the interested respondents. Not responding to this SSN does not preclude participation in any future solicitation, if issued. The purpose of this sources sought synopsis is to gain knowledge of potential qualified vendors to include large business sources, small business sources and their size classifications (i.e., HUBZone 8(a), 8(a), HUBZone, Service-Disabled Veteran-owned, Veteran-Owned, Women-Owned Small Business, and Small Disadvantaged Business) relative to the North American Industry Classification System (NAICS) code.

Responses to this Sources Sought Notice will be used by the Government to make appropriate determinations about potential sources.

Project Title: Research and Development of the FDA ARGOS System



Background/Overview:



Many infectious diseases have similar signs and symptoms, making it challenging for health care providers to identify the disease-causing agent. Clinical samples are often tested by multiple test methods to help reveal the particular microbe that is causing the infectious disease. The results of these test methods can help health care professionals determine the best treatment for patients. High-Throughput Sequencing (HTS) or Next Generation Sequencing (NGS) technology has the capability, as a single test, to accomplish what might have required sever...
Active Contract Opportunity
Notice ID : FDA-SSN-75F40125Q00090
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : FOOD AND DRUG ADMINISTRATION
Office: FDA OFFICE OF ACQ GRANT SVCS
General Information
Contract Opportunity Type: Sources Sought (Original)
Original Published Date: Apr 22, 2025 11:41 am EDT
Original Response Date: May 02, 2025 02:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: May 17, 2025
Initiative: None

Classification
Original Set Aside:
Product Service Code: AJ12 - GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance: Silver Spring, MD USA

Documents

 Tender Notice

Attachment-A-STATEMENT-OF-OBJECTIVES-for-IDIQ.pdf

Attachment-B-Vendor-Feedback-Form.pdf